Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision update added: v3.5.0. Revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:30:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T23:36:11.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1; changes are limited to site version metadata and the removal of a non-critical government-funding maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T12:18:26.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:58:58.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added Show glossary and new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; capitalization changes were applied to related text; and the site revision was updated from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T05:48:33.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible changes to study details, documents, or page functionality are observed.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:37.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.